KINTOR PHARMA-B: (1) RE-ELECTION OF RETIRING DIRECTORS; (2) RE-APPOINTMENT OF AUDITOR; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (4) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORA

香港交易所 · May 12, 2023 04:35

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

開拓藥業-B：(1) 重選退任董事； (2) 續聘核數師； (3) 發行股份及購回股份的一般授權； (4) 建議修訂現有組織章程大綱及細則以及採納新組織章程大綱及細則； (5) 建議增加法定股本； 及 (6) 股東週年大會通告

KINTOR PHARMA-B: (1) RE-ELECTION OF RETIRING DIRECTORS; (2) RE-APPOINTMENT OF AUDITOR; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (4) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORA

Risk Disclaimer

Statement

開拓藥業-B：(1) 重選退任董事； (2) 續聘核數師； (3) 發行股份及購回股份的一般授權； (4) 建議修訂現有組織章程大綱及細則以及採納新組織章程大綱及細則； (5) 建議增加法定股本；及 (6) 股東週年大會通告